OtherMinireview
The Nonclinical Disposition and PK/PD Properties of GalNAc-conjugated siRNA Are Highly Predictable and Build Confidence in Translation to Man
Saeho Chong, Sagar Agarwal, Saket Agarwal, Krishna C. Aluri, Michael Arciprete, Christopher Brown, Klaus Charisse, Joseph Cichocki, Kevin Fitzgerald, Varun Goel, Yongli Gu, Dale Guenther, Bahru Habtemariam, Vasant Jadhav, Maja Janas, Muthusamy Jayaraman, Jeff Kurz, Jing Li, Steven Liou, Ju Liu, Xiumin Liu, Christopher Maclauchlin, Martin Maier, Muthiah Manoharan, Robin McDougall, Jay Nair, Diane Ramsden, Gabriel Robbie, Karyn Schmidt, Peter Smith, Christopher Theile, Akshay Vaishnaw, Scott Waldron, Jing-Tao Wu, Yuanxin Xu, Xuemei Zhang, Ivan Zlatev and Elena castellanos-Rizaldos
Drug Metabolism and Disposition June 21, 2021, DMD-MR-2021-000428; DOI: https://doi.org/10.1124/dmd.121.000428
Saeho Chong
1Drug Metabolism and Pharmacokinetics, Alnylam Pharmaceuticals Inc., United States
Sagar Agarwal
2Clinical Pharmacology, Alnylam Pharmaceuticals, United States
Saket Agarwal
3Investigative Toxicology, Alnylam Pharmaceuticals, United States
Krishna C. Aluri
4Early Development, Alnylam pharmaceuticals, United States
Michael Arciprete
5Alnylam Pharmaceuticals Inc., United States
Christopher Brown
6Biology, Alnylam Pharmaceuticals, United States
Klaus Charisse
7Chemistry, Alnylam Pharmaceuticals, United States
Joseph Cichocki
8Toxicology, Vertex Pharmaceuticals, United States
Kevin Fitzgerald
9Research, Alnylam Pharmaceuticals, United States
Varun Goel
10Clinical Pharmacology, Avidity Bioscience, United States
Yongli Gu
11Bioanalytical Science, Alnylam Pharmaceuticals, United States
Dale Guenther
12RNAi Discovery, Alnylam Pharmaceuticals, United States
Bahru Habtemariam
2Clinical Pharmacology, Alnylam Pharmaceuticals, United States
Vasant Jadhav
6Biology, Alnylam Pharmaceuticals, United States
Maja Janas
3Investigative Toxicology, Alnylam Pharmaceuticals, United States
Muthusamy Jayaraman
13CRISPR Therapeutics, United States
Jeff Kurz
14DMPK, Alnylam Pharmaceuticals, United States
Jing Li
5Alnylam Pharmaceuticals Inc., United States
Steven Liou
14DMPK, Alnylam Pharmaceuticals, United States
Ju Liu
5Alnylam Pharmaceuticals Inc., United States
Xiumin Liu
14DMPK, Alnylam Pharmaceuticals, United States
Christopher Maclauchlin
14DMPK, Alnylam Pharmaceuticals, United States
Martin Maier
14DMPK, Alnylam Pharmaceuticals, United States
Muthiah Manoharan
9Research, Alnylam Pharmaceuticals, United States
Robin McDougall
1Drug Metabolism and Pharmacokinetics, Alnylam Pharmaceuticals Inc., United States
Jay Nair
7Chemistry, Alnylam Pharmaceuticals, United States
Diane Ramsden
15DMPK, Takeda, United States
Gabriel Robbie
2Clinical Pharmacology, Alnylam Pharmaceuticals, United States
Karyn Schmidt
6Biology, Alnylam Pharmaceuticals, United States
Peter Smith
5Alnylam Pharmaceuticals Inc., United States
Christopher Theile
7Chemistry, Alnylam Pharmaceuticals, United States
Akshay Vaishnaw
9Research, Alnylam Pharmaceuticals, United States
Scott Waldron
9Research, Alnylam Pharmaceuticals, United States
Jing-Tao Wu
16DMPK, Alnylam, United States
Yuanxin Xu
5Alnylam Pharmaceuticals Inc., United States
Xuemei Zhang
5Alnylam Pharmaceuticals Inc., United States
Ivan Zlatev
7Chemistry, Alnylam Pharmaceuticals, United States
Elena castellanos-Rizaldos
6Biology, Alnylam Pharmaceuticals, United States
Article Figures & Data
Additional Files
Data Supplement
- Supplemental Data -
Methods
Supplemental Table 1 - In vitro evaluation of single and duplex stability in the presence of enzymes known to cleave RNA and DNA.
Supplemental Table 2 - Cross species metabolite profiles from plated hepatocytes and nonclinical liver samples.
Supplemental Figure 1 - Electrophoretic mobility shift assay (EMSA) results for siRNA2 and siRNA19 following a 1:1 mixture of sense strands (SS), antisense strands (AS) and duplex strands in PBS (Panel A).
Supplemental Figure 2 - Evaluation of sense strand metabolites in rat (Panel A) and monkey (Panel B) liver samples following SC administration of siRNA6.
- Supplemental Data -
In this issue
OtherMinireview
Disposition and PK/PD of GalNAc-siRNA
Saeho Chong, Sagar Agarwal, Saket Agarwal, Krishna C. Aluri, Michael Arciprete, Christopher Brown, Klaus Charisse, Joseph Cichocki, Kevin Fitzgerald, Varun Goel, Yongli Gu, Dale Guenther, Bahru Habtemariam, Vasant Jadhav, Maja Janas, Muthusamy Jayaraman, Jeff Kurz, Jing Li, Steven Liou, Ju Liu, Xiumin Liu, Christopher Maclauchlin, Martin Maier, Muthiah Manoharan, Robin McDougall, Jay Nair, Diane Ramsden, Gabriel Robbie, Karyn Schmidt, Peter Smith, Christopher Theile, Akshay Vaishnaw, Scott Waldron, Jing-Tao Wu, Yuanxin Xu, Xuemei Zhang, Ivan Zlatev and Elena castellanos-Rizaldos
Drug Metabolism and Disposition June 21, 2021, DMD-MR-2021-000428; DOI: https://doi.org/10.1124/dmd.121.000428
OtherMinireview
Disposition and PK/PD of GalNAc-siRNA
Saeho Chong, Sagar Agarwal, Saket Agarwal, Krishna C. Aluri, Michael Arciprete, Christopher Brown, Klaus Charisse, Joseph Cichocki, Kevin Fitzgerald, Varun Goel, Yongli Gu, Dale Guenther, Bahru Habtemariam, Vasant Jadhav, Maja Janas, Muthusamy Jayaraman, Jeff Kurz, Jing Li, Steven Liou, Ju Liu, Xiumin Liu, Christopher Maclauchlin, Martin Maier, Muthiah Manoharan, Robin McDougall, Jay Nair, Diane Ramsden, Gabriel Robbie, Karyn Schmidt, Peter Smith, Christopher Theile, Akshay Vaishnaw, Scott Waldron, Jing-Tao Wu, Yuanxin Xu, Xuemei Zhang, Ivan Zlatev and Elena castellanos-Rizaldos
Drug Metabolism and Disposition June 21, 2021, DMD-MR-2021-000428; DOI: https://doi.org/10.1124/dmd.121.000428
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement